Susanne Fiedler - 29 Mar 2024 Form 4 Insider Report for Organon & Co. (OGN)

Reporting relationship: Chief Commercial Officer
Issuer ticker: OGN
Reported as of: 29 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Apr 2024, 16:27:29 UTC
Prior SEC filing: 01 Mar 2024
Next SEC filing: 03 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/ Tarnetta V. Jones, as Attorney-in-Fact for Susanne Fiedler

Key filing fact

Susanne Fiedler filed Form 4 for Organon & Co. (OGN) on 02 Apr 2024.

Key facts

This page summarizes Susanne Fiedler's Form 4 filing for Organon & Co. (OGN).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 02 Apr 2024, 16:27.

Change

Previous filing in this sequence was filed on 01 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGN transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +29,255
Change %
Price: $0.000000
Shares after: 29,255
Date: 29 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 29,255
Exercise price
Footnotes: F1, F2

OGN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +119,825
Change %
Price: $0.000000
Shares after: 119,825
Date: 29 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 119,825
Exercise price: $18.80
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.

Footnote F2

These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.

Footnote F3

The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027.